These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2605007)

  • 41. [Invasive adjuvant therapy after pharmacological thrombolysis: why and when? Can we answer these questions right now?].
    Sousa AG; Sousa JE
    Arq Bras Cardiol; 1992 Oct; 59(4):331-3. PubMed ID: 1341191
    [No Abstract]   [Full Text] [Related]  

  • 42. Pathophysiological basis of the treatment of ischemic heart disease.
    Condorelli M
    Ann Ital Med Int; 1990; 5(3 Pt 3):322-4. PubMed ID: 2081092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does preventive PCI work?
    Hochman JS; Steg PG
    N Engl J Med; 2007 Apr; 356(15):1572-4. PubMed ID: 17387128
    [No Abstract]   [Full Text] [Related]  

  • 44. [Prevention of complications and the methods of increasing the safety of percutaneous transluminal coronary angioplasty (PTCA)].
    Dabrowski M
    Kardiol Pol; 1992 Nov; 37(11):321-6. PubMed ID: 1287296
    [No Abstract]   [Full Text] [Related]  

  • 45. Coronary sinus interventions: state of the art and initial clinical experience with retroperfusion support during angioplasty.
    Haendchen RV; Corday E
    Arq Bras Cardiol; 1990 May; 54(5):293-305. PubMed ID: 2288516
    [No Abstract]   [Full Text] [Related]  

  • 46. Door-to-balloon time: are we evaluating the wrong metric?
    Peterman JM; George A; Giugliano GR; Schweiger MJ
    J Am Coll Cardiol; 2010 Jul; 56(2):158-9. PubMed ID: 20620732
    [No Abstract]   [Full Text] [Related]  

  • 47. Percutaneous transluminal coronary angioplasty with hemoperfusion.
    Snyder R; Wijay B; Angelini P
    ASAIO Trans; 1991; 37(3):M367-8. PubMed ID: 1751190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Finding the courage to reconsider medical therapy for stable angina.
    Peterson ED; Rumsfeld JS
    N Engl J Med; 2008 Aug; 359(7):751-3. PubMed ID: 18703479
    [No Abstract]   [Full Text] [Related]  

  • 49. [Epidemiology and biostatistics in medical research, vol. 2 (causation and association, study design and biases)].
    Kuwabara Y; Saito T; Inagaki Y
    Kokyu To Junkan; 1992 Feb; 40(2):137-44. PubMed ID: 1565878
    [No Abstract]   [Full Text] [Related]  

  • 50. Strategies for reestablishing coronary blood flow during the acute phase of myocardial infarction.
    Louie EK; Langholz D
    Chest; 1994 Feb; 105(2):574-84. PubMed ID: 8306766
    [No Abstract]   [Full Text] [Related]  

  • 51. [Clinical application of special emergency therapy and its limitations: percutaneous transluminal coronary recanalization].
    Kanmatsuse K; Nagao K; Onikura S; Kajiwara N
    Nihon Rinsho; 1986 Jun; 44(6):1432-8. PubMed ID: 2945014
    [No Abstract]   [Full Text] [Related]  

  • 52. Editorial: After a coronary.
    Br Med J; 1975 Apr; 2(5963):103-5. PubMed ID: 1125693
    [No Abstract]   [Full Text] [Related]  

  • 53. Office emergency: coronary heart disease.
    McCarthy FM
    Dent Surv; 1977 Dec; 53(12):23-6. PubMed ID: 274424
    [No Abstract]   [Full Text] [Related]  

  • 54. [Quantitative analysis of reperfusion therapy for acute myocardial infarction using positron emission tomography].
    Yamamoto Y; Nonogi H; Iida H; de Silva R; Maseri A; Jones T
    Jpn Circ J; 1993; 57 Suppl 4():1358-60. PubMed ID: 7966986
    [No Abstract]   [Full Text] [Related]  

  • 55. Hazards in the evaluation of secondary prevention trials.
    Detre K; Kuller LH
    Am J Epidemiol; 1979 Apr; 109(4):400-4. PubMed ID: 443239
    [No Abstract]   [Full Text] [Related]  

  • 56. [Bases for the differential therapy of chronic ischemic heart disease].
    Shkhvatsabaia IK
    Kardiologiia; 1978 Jun; 18(6):10-8. PubMed ID: 672002
    [No Abstract]   [Full Text] [Related]  

  • 57. Maximum myocardial blood flow and angioplasty.
    Wilson RF; Laxson DD
    Circulation; 1991 Dec; 84(6):2604-6. PubMed ID: 1801789
    [No Abstract]   [Full Text] [Related]  

  • 58. Thrombolytic therapy and implications for the clinical laboratory.
    Keffer JH
    Am J Clin Pathol; 1996 Jan; 105(1):1-2. PubMed ID: 8561073
    [No Abstract]   [Full Text] [Related]  

  • 59. Treating myocardial infarction: importance of early reperfusion.
    Grines CL; Weaver WD
    Lancet; 1994 Aug; 344(8921):490-1. PubMed ID: 7914609
    [No Abstract]   [Full Text] [Related]  

  • 60. Applying the open artery theory: use of predictive survival markers.
    White HD; Braunwald E
    Eur Heart J; 1998 Aug; 19(8):1132-9. PubMed ID: 9740337
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.